about
Diagnosis and management of subclinical hypothyroidism in pregnancyApproach to the Patient with Postpartum ThyroiditisGuidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartumPostpartum Management of Women Begun on Levothyroxine during PregnancyThe thyroid and pregnancy: a novel risk factor for very preterm delivery.Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline.Potential risks of excess iodine ingestion and exposure: statement by the american thyroid association public health committee.Thyroid autoimmunity and the risk of miscarriage.Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis.Overt hyperthyroidism and hypothyroidism during pregnancy.Controversies in endocrinology: On the need for universal thyroid screening in pregnant women.Clinical aspects of hyperthyroidism, hypothyroidism, and thyroid screening in pregnancy.Maternal subclinical hypothyroidsm and gestational diabetes mellitus: a meta-analysis.Marginal Iodine Status and High Rate of Subclinical Hypothyroidism in Washington DC Women Planning Conception.High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy.Interdisciplinary clerkships: educational models of the future?Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy.Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy.Implementing an Entrustable Professional Activities Framework in Undergraduate Medical Education: Early Lessons From the AAMC Core Entrustable Professional Activities for Entering Residency Pilot.Iodine and pregnancy: a call to action.Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women.AAP recommendations on iodine nutrition during pregnancy and lactation.Teaching behavior change concepts and skills during the third-year medicine clerkship.Is universal screening for thyroid disease in pregnancy a cost-effective strategy?Development of a mission-based funding model for undergraduate medical education: incorporation of quality.Competency in electrocardiogram interpretation among graduating medical students.Clinical guidelines: Thyroid and pregnancy - time for universal screening?Impact of Levothyroxine in Miscarriage and Preterm Delivery Rates in First Trimester Thyroid Antibody-Positive Women With TSH Less Than 2.5 mIU/L.Developing a complementary, alternative, and integrative medicine course: one medical school's experience.Universal Screening Versus Case Finding for Detection and Treatment of Thyroid Hormonal Dysfunction During PregnancyThyroid Antibody Positivity in the First Trimester of Pregnancy Is Associated with Negative Pregnancy OutcomesAmbulatory education: expanding undergraduate experience in medical education. A CDIM commentary.A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunctionECG as an Entrustable Professional Activity: CDIM Survey Results, ECG Teaching and Assessment in the Third YearErratum: Maternal thyroid function in pregnancy — a tale of two tailsMaternal thyroid function in pregnancy — a tale of two tailsAttitudes of ATA Survey Respondents Toward Screening and Treatment of Hypothyroidism in PregnancyIodine Supplements During and After Pregnancy—ReplyIodine Supplementation During Pregnancy and LactationOptimal Care of the Pregnant Woman with Thyroid Disease
P50
Q22299323-164DE370-322A-47DA-AFA7-F283AA614B10Q22306205-6BE57CB1-7A7C-419A-AF49-A0BA806C1C76Q24628836-810C1DB3-AA0C-41CB-AD33-4F87C1C22FDEQ26773147-20DFEDE8-ADE4-4FD2-A608-0046CA707356Q34416307-E2E9C4E1-C601-4BEC-A3DF-B68C9D2A7CECQ34703770-A50EFCE5-6636-4448-8FFB-A37AE8C58368Q35064065-F61F52EB-AFF5-4BDD-BEE8-1B7EEABB4816Q35781097-65E2CDDD-3B95-4F03-A777-4CB2357E64E7Q36945400-65888BA9-59B9-4393-839A-B27F84206A61Q37920557-60F7D255-99FB-4351-AC85-BC285411FA9EQ38152841-48B20CB2-CC28-4927-9767-7BBB525C24AAQ38180678-B51D3D93-9C97-4E11-8A51-953930FBDB63Q38180682-6BEB8943-DD76-4BD8-86C3-0907F012B1F4Q38986334-8BDCE4B1-7FAF-4424-9C7E-197D07F4403CQ39800696-E794D47A-4941-476A-ADCF-5C78ED0D4BEEQ40968499-66BFAECF-3E8E-4BC0-BBAB-BC2AD82587C2Q43037148-36FDD244-F339-4A13-B15A-99A8C0D4F878Q43174702-21E2E292-2291-46AA-B198-97496940ED65Q45060171-4F92ADC9-A26F-42B6-8827-1CA05E7A796AQ45358212-00490869-A75B-4488-840F-B6C767E67B17Q46295230-AA026F51-B08E-4E97-BE52-8D05035D3DBEQ46862701-0B8DE111-BD52-4817-96DD-39704974A805Q47586926-63EB52FE-4208-42D2-83E2-B39877BEE5B5Q50622628-3A35A915-2546-44B4-9DFD-812B220BBF99Q50636856-594F1E84-5FFF-49DE-B300-448504C53F57Q50658867-EE531918-F501-4359-98D8-8E4BEDF3D24FQ50875773-086C7952-788E-4B14-8418-71600839C583Q51615756-B228660E-5A52-4CA1-99C3-16D403669DF7Q51771770-259371DA-5505-435E-8EC9-1BE1CE3C6485Q53058670-A123FC21-7DC4-42EA-A8A8-B6EA25C5A44DQ53102500-A8E4FBC9-7CF2-4F5B-BB7B-01BDCC7E9141Q54695286-D5C66C46-2980-4C4B-81BA-C1FEF21CD6DAQ57223601-9E54EF64-1ABA-4064-B15A-36E6130E613DQ59742690-15E58C91-0870-440D-B2F1-9F03FB6F92F6Q59742701-80018728-46C4-4F1A-A89B-B1038200EC11Q59742717-983AD016-6502-480D-B52E-DAB91D09CB48Q59742727-660E9A3E-0748-49C7-8C57-C9DE8C62B26DQ59742831-D2ACDF8D-2776-497A-B5DE-EAA0549663ABQ59742878-99C85DFE-6932-4EE8-8CA0-F59045F0F276Q59742889-583ACE28-6219-48E0-BE04-01176B522B6B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alex Stagnaro-Green
@ast
Alex Stagnaro-Green
@en
Alex Stagnaro-Green
@es
Alex Stagnaro-Green
@nl
type
label
Alex Stagnaro-Green
@ast
Alex Stagnaro-Green
@en
Alex Stagnaro-Green
@es
Alex Stagnaro-Green
@nl
prefLabel
Alex Stagnaro-Green
@ast
Alex Stagnaro-Green
@en
Alex Stagnaro-Green
@es
Alex Stagnaro-Green
@nl
P106
P1153
7003655734
P21
P31
P496
0000-0003-2434-3852